Lam Research Corporation (LRCX) Bundle
You're looking at Lam Research Corporation (LRCX), a critical gear in the semiconductor machine, and you need to know if their financial health supports the AI hype. The short answer is yes, the numbers from the 2025 fiscal year (FY) are defintely strong, but you have to look past the headline revenue to the underlying efficiency and geographic risk. Lam Research closed out FY 2025 with a record annual revenue of over $18.44 billion and a record free cash flow generation of about $5.41 billion, showing they can turn sales into real cash. But here's the quick math: their September 2025 quarter revenue hit a record $5.32 billion, with a non-GAAP operating margin that also set a record at 35.0%, largely fueled by a huge 43% revenue concentration from China. This concentration, plus the slight sequential dip in the December quarter revenue guidance to a midpoint of $5.20 billion, is the near-term tension you need to watch, even as the overall Wafer Fabrication Equipment (WFE) market outlook for 2025 is now a robust $105 billion, driven by High Bandwidth Memory (HBM) investments for AI. That AI story is real, but the near-term execution is where the action is.
Revenue Analysis
You need to know where Lam Research Corporation (LRCX) is making its money, and the short answer is: they are selling a lot of equipment, and the growth is strong. For the fiscal year 2025 (FY2025), which ended in June, Lam Research Corporation reported total annual revenue of $18.44 billion, representing a substantial year-over-year increase of 23.68% from the prior fiscal year. That's a powerful rebound from the semiconductor downturn.
The primary revenue streams for Lam Research Corporation fall into two main buckets: Systems and Customer Support-Related Group (CSBG). The Systems segment, which covers the sale of new wafer fabrication equipment like their deposition and etch tools, is the clear revenue driver. In FY2025, Systems revenue hit $11.49 billion, accounting for 62.33% of the total revenue. The remaining 37.67%, or $6.94 billion, came from the CSBG segment, which includes sales of spares, upgrades, and services. It's a healthy mix, but the equipment sales defintely lead the way.
Looking at the most recent quarter (Q3 2025, ending September 28, 2025), the company's revenue was $5.32 billion, showing a sequential increase of 3% from the June quarter, plus a strong year-over-year jump of 27.7%. This continued momentum is driven by specific end-markets within the Systems segment.
Here's the quick math on where the Systems revenue is flowing, based on the September 2025 quarter:
- Foundry: 60% of Systems revenue.
- NVM (Non-volatile memory): 18% of Systems revenue.
- DRAM: 16% of Systems revenue.
- Logic/Other: 6% of Systems revenue.
The 60% reliance on Foundry is significant; it shows Lam Research Corporation is deeply embedded in the manufacturing of chips for diverse applications, including the crucial artificial intelligence (AI) sector. This is where the near-term opportunity is mapped.
What this estimate hides is the geographic concentration, which is a key risk factor. The biggest change in the revenue stream is the massive contribution from one region. In the September 2025 quarter, the geographic distribution was heavily skewed toward Asia, with China alone accounting for a striking 43% of total revenue. Taiwan followed at 19%, and Korea at 15%. This concentration in China, while fueling growth, exposes the company to geopolitical trade policy shifts, so you need to keep a close eye on export control developments.
The overall picture is one of high growth, driven by equipment sales for foundry applications, but with a clear geographic risk that needs to be factored into your valuation models. For a deeper dive into the valuation tools and strategic frameworks we use, check out Breaking Down Lam Research Corporation (LRCX) Financial Health: Key Insights for Investors.
| Revenue Segment (FY2025) | Amount | Contribution to Total Revenue |
|---|---|---|
| Systems Revenue | $11.49 Billion | 62.33% |
| Customer Support and Other Revenue (CSBG) | $6.94 Billion | 37.67% |
| Total Annual Revenue (FY2025) | $18.44 Billion | 100% |
Profitability Metrics
If you're looking at Lam Research Corporation (LRCX), the direct takeaway is this: the company is a profitability powerhouse in the semiconductor equipment space, turning a significant portion of every revenue dollar into pure profit. Their margins for the 2025 fiscal year are not just good; they are defintely best-in-class, showing exceptional operational efficiency and strong pricing power.
Lam Research Corporation (LRCX) closed its 2025 fiscal year with impressive profitability metrics, driven by high demand for its wafer fabrication equipment (WFE) in the AI and memory markets. The company's ability to manage costs while scaling production is the key story here, leading to a substantial increase in both gross and operating income year-over-year.
- Gross Profit Margin (Non-GAAP, Sep 2025 Q): 50.6%
- Operating Margin (Non-GAAP, Sep 2025 Q): 35.0%
- Net Profit Margin (FY 2025): 29.66%
Operational Efficiency and Cost Management
The most telling sign of a well-run manufacturing business is its Gross Profit Margin, which shows how efficiently it converts raw materials and labor into products. Lam Research Corporation (LRCX)'s non-GAAP gross margin of 50.6% for the September 2025 quarter is a clear indicator of superior operational execution. This level of margin, consistently above the 50% mark, suggests a strong competitive moat-likely due to their specialized deposition and etch technologies-and effective cost management (Cost of Goods Sold).
This efficiency translates directly to the bottom line. Annual gross profit for the 2025 fiscal year hit $8.979 billion, a 27.31% increase from the prior year. Here's the quick math: high gross margin plus strong revenue growth means massive absolute profit generation. You want to see this kind of sustained margin strength, especially as the industry moves through cyclical upturns.
Profitability Trends and Industry Comparison
Looking at the trend, Lam Research Corporation (LRCX) is accelerating its profitability. Annual operating income for 2025 was $5.901 billion, marking a sharp 38.39% increase from 2024. This jump in operating income, which outpaced the gross profit increase, shows that the company is also controlling its operating expenses (OpEx) well, a sign of smart overhead management. The operating margin of 35.0% is proof that their margin expansion strategy is working.
When you stack Lam Research Corporation (LRCX) against its peers in the Semiconductor Equipment & Materials industry, its performance is even more compelling. The industry average net profit margin is approximately 23.33%. Lam Research Corporation (LRCX)'s net margin of 29.66% is significantly higher, placing it in the top tier for converting sales into net income. This premium margin indicates a superior business model and a dominant market position. For a deeper dive into who is betting on this performance, you can read Exploring Lam Research Corporation (LRCX) Investor Profile: Who's Buying and Why?
| Profitability Metric | Lam Research Corporation (LRCX) (FY 2025) | Industry Average (Semiconductor Equipment) | LRCX Performance vs. Industry |
|---|---|---|---|
| Gross Margin (Non-GAAP) | 50.6% | N/A (But consistently high) | Superior |
| Operating Margin (Non-GAAP) | 35.0% | N/A (But very high) | Superior |
| Net Profit Margin | 29.66% | 23.33% | Outperforms by over 6 percentage points |
| Operating Income Growth (YoY) | 38.39% | N/A | Strong Growth |
Debt vs. Equity Structure
Lam Research Corporation (LRCX) maintains a conservative and healthy capital structure, relying more on shareholder equity than debt to finance its operations and growth. This is a strong signal of financial stability, which is defintely what you want to see in a cyclical industry like semiconductor equipment.
As of the quarter ending September 2025, the company's total debt stood at approximately $4.48 Billion USD. This total is split between a manageable short-term debt and a larger long-term obligation, indicating a planned and structured approach to its liabilities.
- Short-Term Debt (Current Portion): Roughly $754 Million.
- Long-Term Debt: Approximately $3.73 Billion.
Here's the quick math on how Lam Research Corporation balances its funding:
| Metric | Value (as of Sep. 2025) | Notes |
|---|---|---|
| Total Debt | $4.48 Billion | Sum of short-term and long-term debt. |
| Total Stockholders' Equity | $10.19 Billion | The core capital base. |
| Debt-to-Equity (D/E) Ratio | 0.44 | Debt for every dollar of equity. |
| Industry Average D/E Ratio | 0.34 | Semiconductor Equipment & Materials sector. |
The company's Debt-to-Equity (D/E) ratio of 0.44 (as of September 2025) is slightly above the Semiconductor Equipment & Materials industry average of 0.34. To be fair, a ratio below 1.0 is generally considered excellent, meaning equity far outweighs debt. Lam Research Corporation's ratio is still very low, confirming a strong financial foundation where its assets are primarily funded by ownership capital, not borrowings. This low leverage reduces financial risk, especially during industry downturns. The company could theoretically pay off all its debt in less than a year using its current free cash flow, which is a very strong position.
In terms of recent activity, the debt structure has remained quite stable. There have been no major, recent debt issuances or refinancing announcements that significantly alter the capital structure, which is a sign of a steady financing strategy. The focus appears to be on generating cash internally and returning capital to shareholders, rather than aggressive debt-fueled expansion. This is a mature company approach. For a deeper dive into who is backing this capital structure, check out Exploring Lam Research Corporation (LRCX) Investor Profile: Who's Buying and Why?
Liquidity and Solvency
You need to know if Lam Research Corporation (LRCX) has the cash to cover its near-term bills and fund its growth, and the short answer is yes, but the liquidity picture shows a strategic shift. The company's financial health is strong, anchored by robust cash generation, but its liquidity ratios have tightened a bit, which is worth watching.
For the fiscal year ended June 29, 2025, Lam Research Corporation's liquidity ratios are solid, though they have trended downward from prior years. The Current Ratio sits at 2.21, meaning the company has $2.21 in current assets for every dollar of current liabilities. The Quick Ratio (or acid-test ratio), which strips out inventory-a less liquid asset-is still a healthy 1.60. Anything over 1.0 is generally good, so even the quick ratio shows a comfortable buffer to meet immediate obligations without rushing to sell equipment inventory.
Here's the quick math on their short-term position:
- Current Ratio (FY 2025): 2.21
- Quick Ratio (FY 2025): 1.60
The trend in working capital (current assets minus current liabilities) is the key insight here. The Current Ratio has generally declined from a high of 3.43 in 2020 to the current 2.21, suggesting a reduction in the cushion available to cover current liabilities. This is partly due to a notable spike in current liabilities, which increased to approximately $6.57 billion in June 2025. This increase could be a sign of higher deferred revenue (customer prepayments) or increased short-term payables as the business scales, but it defintely warrants closer attention to the Mission Statement, Vision, & Core Values of Lam Research Corporation (LRCX).
The cash flow statement for the 2025 fiscal year tells a story of significant operational strength, which is the ultimate source of liquidity. Lam Research Corporation generated $6,173 million in cash from operating activities (CFO). This massive inflow easily covers their capital expenditures (CapEx) for the year, which totaled -$759.19 million. This leaves a very strong Free Cash Flow (FCF) of $5.41 billion, which is the cash left over after funding the business's growth.
The cash flow breakdown looks like this (in millions USD):
| Cash Flow Activity | FY 2025 Amount | Trend/Implication |
|---|---|---|
| Operating Cash Flow (CFO) | $6,173 | Very strong, core business is highly cash-generative. |
| Investing Cash Flow (CFI) - CapEx | -$759.19 | Moderate investment in property, plant, and equipment. |
| Free Cash Flow (FCF) | $5,410 | Excellent, provides ample capital for shareholder returns. |
The financing cash flow is where the FCF is deployed. The cash, cash equivalents, and restricted cash balances still increased to $6.4 billion by the end of June 2025, even after deploying cash for capital return activities like dividends and share repurchases. This consistent cash generation is a major strength, allowing the company to maintain a low-debt profile-long-term debt was reported at $3.73 billion as of September 2025. So, while the ratios are lower, the sheer volume of cash being generated mitigates any immediate liquidity concerns, keeping the overall solvency picture healthy.
Valuation Analysis
You're looking at Lam Research Corporation (LRCX) after a massive run, and the core question is simple: Is there any gas left in the tank, or is it overvalued? The quick answer is that traditional metrics suggest a premium, but the market is pricing in significant future growth in the semiconductor equipment cycle.
The stock's valuation multiples, as of late 2025, are elevated compared to historical averages, reflecting the strong demand outlook for wafer fabrication equipment (WFE). For instance, the trailing twelve-month (TTM) Price-to-Earnings (P/E) ratio sits at approximately 32.54.
Here's the quick math on the key valuation multiples for Lam Research Corporation (LRCX) compared to its sector peers:
| Valuation Metric (TTM, Nov 2025) | Lam Research Corporation (LRCX) | Sector Median (Semiconductors) | Implication |
|---|---|---|---|
| Price-to-Earnings (P/E) | 32.54 | ~35.9x (Peer/Industry Average) | Slightly below peers, but high historically. |
| Price-to-Book (P/B) | 18.32 | ~4.0x (Sector Average) | Significant premium, reflecting high return on equity. |
| Enterprise Value-to-EBITDA (EV/EBITDA) | 26.68 | ~19.98x (Industry Median) | Trading at a premium to the industry median. [cite: 16 from first search] |
The Price-to-Book (P/B) ratio of around 18.32 is defintely a huge red flag on its own, but for a capital-light, high-tech equipment maker, a high P/B is common. The market is essentially telling you that the book value (assets minus liabilities) dramatically understates the true value of their intellectual property and market position. Still, a P/E of 32.54 and an EV/EBITDA of 26.68 show that expectations for earnings growth are already substantially baked into the price.
Stock Momentum and Dividend Stability
The stock price trend over the last 12 months has been phenomenal, driven by the AI-fueled demand for advanced chip manufacturing. Lam Research Corporation (LRCX) stock has surged over 108.66% in the past year, with its 52-week price range spanning from a low of $56.32 in April 2025 to a high of $167.15 in November 2025. [cite: 3 from first search, 7 from first search] That kind of performance is spectacular, but it also increases the risk of a near-term pullback.
On the income front, the company offers a modest but growing dividend. The annual dividend is currently $1.04 per share, translating to a dividend yield of approximately 0.7%. [cite: 8 from first search, 2 from first search] The dividend payout ratio is very healthy at about 22.91%, meaning Lam Research Corporation is paying out less than a quarter of its earnings, leaving plenty of capital for reinvestment and future dividend hikes. [cite: 8 from first search]
- Stock price up 108.66% in the last 12 months. [cite: 3 from first search]
- Annual dividend of $1.04 per share. [cite: 8 from first search]
- Low payout ratio of 22.91% signals dividend safety. [cite: 8 from first search]
Analyst Consensus and Actionable Takeaway
The analyst community generally maintains a bullish stance, with a consensus rating of 'Moderate Buy.' [cite: 11 from first search] The average 12-month price target is around $149.04, which is close to the recent trading price, suggesting that the stock is currently near its fair value as estimated by the street. [cite: 11 from first search, 13 from first search] Some models, like one with a fair value of $158.02, see the stock as slightly overvalued by about 2.2%. [cite: 5 from first search] The overall sentiment is that the stock is fairly priced for its near-term outlook, but the long-term secular growth story remains intact.
What this estimate hides is the potential for a cyclical downturn in the semiconductor industry, which could quickly re-rate the high P/E multiple. For a deeper dive into who is driving this price action, you should read Exploring Lam Research Corporation (LRCX) Investor Profile: Who's Buying and Why?
Your action item is to not initiate a large new position at these elevated multiples, but rather to use any significant market dips-say, a 10% correction-as an opportunity to build a position, betting on the long-term growth of the wafer fabrication equipment market.
Risk Factors
You're looking at Lam Research Corporation (LRCX) because of its strong position in the semiconductor equipment market, but you defintely need to map out the risks. The core challenge for LRCX is a tightrope walk between geopolitical headwinds and the cyclical nature of the industry, even with record operational performance in 2025.
The most immediate and significant risk is the ongoing geopolitical tension, specifically the U.S. export regulations impacting sales to China. China has been a massive market, previously accounting for nearly two-fifths of revenue. Now, management is guiding for China sales to normalize to around 30% of total revenue. Here's the quick math on the direct impact: the U.S. government's '50% rule' on exports is projected to hit sales by approximately $600 million in calendar year 2026, following an expected $200 million impact in the December 2025 quarter. That's a material headwind.
Beyond the regulatory environment, the semiconductor industry is inherently cyclical, meaning demand and pricing can be volatile. LRCX's stock volatility, indicated by a Beta of 1.96, reflects this market sensitivity. You also have to consider customer concentration-relying on a limited number of key customers means a sudden shift in one company's capital expenditure (capex) plan could quickly affect LRCX's top line. This is a risk you must monitor closely, especially as we move into 2026.
Operational and financial risks, while less severe than the geopolitical ones, are still worth noting. While the company posted a record non-GAAP gross margin of 50.6% and non-GAAP operating margin of 35.0% for the September 2025 quarter, guidance for the December quarter suggests a dip. Management forecasts the gross margin to decline to 48.5% (±1%) and the operating margin to 33.0% (±1%). This margin compression signals either a less profitable product mix or the upfront costs of ramping up production for next-generation tools.
- Geopolitical Tensions: U.S. export controls on China.
- Market Cyclicality: High stock volatility (Beta 1.96).
- Customer Concentration: Reliance on a few large customers.
- Margin Compression: Near-term dip to 48.5% gross margin guided.
What this estimate hides is the strategic investment in mitigation. Lam Research Corporation is not sitting still. Their strategy is two-pronged: Exploring Lam Research Corporation (LRCX) Investor Profile: Who's Buying and Why? The first is geographical diversification and supply chain resilience. They are actively expanding their global manufacturing footprint, notably with a planned investment of more than $1.2 billion to build a new facility in India, which acts as a strategic hedge against trade restrictions. Second, they are leveraging their strong position in customer support, which provides a stable revenue base (roughly one-third of the business), and focusing on high-growth areas like AI-driven memory and foundry segments, with management expecting demand from regions like the U.S., Taiwan, and Korea to offset the China restrictions.
Here are the key financial metrics from the fiscal year ended June 29, 2025, which underpin their ability to manage these risks:
| Metric | FY 2025 Value (Ended June 29, 2025) |
|---|---|
| Annual Sales | US$18.44 billion |
| Annual Net Income | US$5.36 billion |
| Long-Term Debt (Sept 2025) | $3.73 billion |
| Deferred Revenue (June 2025) | $2.681 billion |
The company's solid financial foundation-with US$18.44 billion in annual sales-gives them the capital to absorb short-term shocks and continue investing in the technology that keeps them competitive, like their Akara etch system and Altus Halo deposition tool. Finance: track the actual December 2025 quarter margins against the 48.5% guidance to gauge the severity of the product mix shift.
Growth Opportunities
You're looking for a clear map of Lam Research Corporation (LRCX)'s future, and the takeaway is this: their growth isn't a gamble on a single technology, but a strategic lock on the most difficult parts of advanced chip manufacturing. They are positioned to outperform the overall Wafer Fabrication Equipment (WFE) market, which is projected to hit around $105 billion in 2025, driven by the intense demands of Artificial Intelligence (AI) and the memory market rebound.
The core of Lam Research Corporation (LRCX)'s near-term growth comes from three clear drivers. First, the complexity of new chips-like those for AI-requires more deposition and etch steps, which expands their total addressable market (SAM). Second, they are winning share with a defintely strong product portfolio. Third, the Customer Support Business Group (CSBG) is growing faster than their installed base as customers seek upgrades and automation.
Here's the quick math on recent performance: in the June 2025 quarter (Q4 FY2025), the company reported revenue of $5.17 billion, beating analyst expectations, with non-GAAP diluted Earnings Per Share (EPS) coming in at $1.33. Analysts are forecasting an overall EPS growth of 15.6% for the full 2025 fiscal year. That's a strong signal of momentum.
Their technological leadership creates a significant competitive moat (a sustainable competitive advantage). It's all about solving the toughest manufacturing problems. They are the tool of record for critical processes at leading customers.
- Gate-All-Around (GAA): Their HALO ALD Moly tool is key for sub-3nm logic chips.
- Advanced Packaging: The SABER 3D system is a best-in-class solution for scaling compute power in AI.
- Next-Gen Patterning: They are investing in Aether dry resist for extreme ultraviolet (EUV) lithography.
- Automation: Dextro collaborative robots (cobots) use AI/ML for predictive maintenance, boosting factory efficiency for clients.
The memory market is also a huge tailwind. The NAND Wafer Fabrication Equipment (WFE) sector is expected to be the fastest-growing segment, and Lam Research Corporation (LRCX) is heavily involved in the technology conversions and upgrades driving that rebound. This is a cyclical recovery they are well-positioned to capitalize on.
Strategic moves are also bolstering their position. In September 2025, Lam Research Corporation (LRCX) announced a cross-licensing and collaboration agreement with JSR Corporation/Inpria Corporation to advance patterning for leading-edge chips, solidifying their grip on the most complex manufacturing steps. Also, the company is actively returning capital to shareholders, with over $2 billion in stock buybacks and a 15% increase in the quarterly dividend. That shows management confidence in future cash flow.
To understand the foundation of their long-term strategy, you should review their core principles: Mission Statement, Vision, & Core Values of Lam Research Corporation (LRCX).
What this estimate hides is the geopolitical risk; China accounted for 35% of their Q2 2025 revenue, so any new trade restrictions could impact sales, but the demand for leading-edge equipment everywhere else is offsetting that. To be fair, the first half of 2025 was a bit lackluster for industry sales overall, but the second half is heating up, largely due to stronger High Bandwidth Memory (HBM) investments critical for AI.
Here is a snapshot of the quarterly financial results for the 2025 fiscal year, which ended in June 2025.
| Quarter Ended | Revenue (in billions) | Non-GAAP EPS | Non-GAAP Gross Margin |
|---|---|---|---|
| September 28, 2025 (Q1 FY2026) | $5.324 | $1.26 | 50.6% |
| June 29, 2025 (Q4 FY2025) | $5.17 | $1.33 | 50.3% |
| March 30, 2025 (Q3 FY2025) | $4.72 | $1.04 | 49.0% |
Finance: Track the Q1 FY2026 guidance for revenue, which is set at a midpoint of $5.20 billion, and non-GAAP EPS of $1.15, plus or minus 10 cents, to confirm the expected sequential dip and margin compression.

Lam Research Corporation (LRCX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.